Befria dig från glasögon och kontaktlinser

EVO ICLTM-proceduren kan hjälpa dig att leva livet utan begränsningar genom att slippa kontaktlinser och glasögon.

Se livet i detalj

Upptäck EVO Implantable Collamer™-linser för att uppnå visuell frihet och ett liv fyllt med nya upplevelser.

Bye Bye Dry Eye

Orsakar inte torra ögon

EVO ICL orsakar inte torra ögon på grund av kontaktlinser eller ögontorrhetssyndrom, vilket kan innebära en mer bekväm väg mot visuell frihet.

Envision a Life Without Hesitation

Föreställ dig ett liv utan begränsningar

Från att lyfta vikter på gymmet till saltstänkta vågor - med EVO ICL är du alltid redo att leva livet fullt ut.

Experience the More Natural Choice

Additiv procedur

EVO ICL är en synkorrigering i harmoni med ditt naturliga öga, och utförs utan att ta bort hornhinnevävnad.

Mer än 3 miljoner

linser distribuerade över hela världen

Hitta en läkare nu för att boka en konsultation.

99,4%

av de tillfrågade skulle göra ingreppet igen

Redo att upptäcka visuell frihet med EVO ICL? Hitta en läkare idag

Important Safety Information

The ICL is designed for the correction/reduction of myopia in patients, 21 to 60 years of age and for patients 21 years of age or older who have been treated with an intraocular lens, ranging from -0.5 D to -20.0 D with or without astigmatism up to 6.0 D and the correction/reduction of hyperopia in patients, from 21 to 45 years of age and for patients 21 years of age or older who have been treated with an intraocular lens, ranging from +0.5 D to +16.0 D with or without astigmatism up to 6.0 D. In order to be sure that your surgeon will use a ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. Because the Myopic and Hyperopic ICLs correct for distance vision, it does not eliminate the need for reading glasses for those with presbyopia, you may require them at some point, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.

Referenser

References

  1. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-63.
  2. Zhang H, Deng Y, Ma K, Yin H, Tang J. Analysis on the changes of objective indicators of dry eye after implantable collamer lens (ICL) implantation surgery. Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2321-2328.
  3. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
  4. Martínez-Plaza E, López-Miguel A, López-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117-125.
  5. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical Trial. Clin Ophthalmol. 2022;16:1541-53.
  6. Shoja MR, Besharati MR. Dry eye after LASIK for myopia: Incidence and risk factors. Eur J Ophthalmol. 2007;17(1):1-6.
  7. Lee JB, Ryu CH, Kim JH, et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract and Refractive Surgery. 2000;26(9):1326-1331.
  8. Albo C, Nasser T, Szynkarski DT, Nguyen N, Mueller B, Libfraind L, Parkhurst G. A Comprehensive Retrospective Analysis of EVO/EVO+ Implantable Collamer Lens: Evaluating Refractive Outcomes in the Largest Single Center Study of ICL Patients in the United States. Clin Ophthalmol. 2024 Jan 9;18:69-78.
  9. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.